Learning to live with Lewy
Lesson 1: When your beloved, who is at best mildly interested in your basketball team, the Boston Celtics, knows more about them that you do, pay attention.
Lesson 1: When your beloved, who is at best mildly interested in your basketball team, the Boston Celtics, knows more about them that you do, pay attention.
Multiple myeloma remains an incurable disease, despite the development of numerous drug classes and combinations that have contributed to improved overall survival. Immunotherapies directed against…
JCP published research that explores the impact of tardive dyskinesia on patients, a new diagnostic tool, and the effect of LAI-APs.
A majority of young adults can correctly identify at least one sign of opioid overdose, but relatively few know how to administer naloxone,…
Sotorasib was the first approved KRAS inhibitor granted marketing authorisation by the US Food and Drug administration (FDA) by use of the accelerated approval pathway…
Maternal MHrH is a modifiable risk factor that explained a low to moderate risk of adverse birth outcomes in the Northern Territory. The knowledge highlights…
Caribbean small island developing states are becoming increasingly vulnerable to compounding disasters, prominently featuring climate-related hazards and pandemic diseases, which exacerbate existing barriers to cancer…
Peruse the current issue of The Lancet Oncology, a monthly journal covering international issues relevant to clinical cancer specialists worldwide
This systematic review summarizes the state of the field of functional magnetic resonance imaging (fMRI) drug cue reactivity, assesses their potential for biomarker development, and…
The requirement of large-scale expensive cancer screening trials spanning decades creates considerable barriers to the development, commercialisation, and implementation of novel screening tests. One way…
Caribbean small island developing states are becoming increasingly vulnerable to compounding disasters, prominently featuring climate-related hazards and pandemic diseases, which exacerbate existing barriers to cancer…